Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00002067 · ClinicalTrials.gov registry record · Phase 3

A Study Comparing Megestrol Acetate at 800 mg/Day, and Placebo in AIDS Patients With Anorexia and Cachexia

A Phase 3 study of HIV Infections and Cachexia, sponsored by Bristol-Myers Squibb.

Completed
Registry status
Phase 3
Development phase
14
Study locations

NCT00002067: Completed Phase 3 study of HIV Infections and Cachexia, sponsored by Bristol-Myers Squibb.

NCT00002067 is a Phase 3 study of HIV Infections and Cachexia that has completed, run by Bristol-Myers Squibb. The trial reports 14 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00002067, a Phase 3 study of HIV Infections and Cachexia, has completed, sponsored by Bristol-Myers Squibb.

COMPLETED
Registry status
Phase 3
Development phase
14
Study locations

Study Summary

To compare the effects of megestrol acetate and placebo on body weight, anorexia, cachexia, calorie intake, and nutritional parameters of patients with a confirmed diagnosis of AIDS. To determine whether megestrol acetate relative to placebo improves the perception of well-being among AIDS patients with cachexia. To evaluate megestrol acetate's effect on immune function via skin test reactivity, T4/T8 ratio, and total lymphocytes.

Conditions Studied

HIV Infections Cachexia Anorexia

Interventions

  • DRUG Megestrol acetate

Study Locations (14)

California

  • Dr Mark Goldstein - Los Angeles
  • Summitt Med Ctr / San Francisco Gen Hosp - Oakland
  • Palo Alto Veterans Adm Med Ctr / Stanford Univ - Palo Alto
  • Eisenhower Med Ctr - Rancho Mirage
  • UCD Med Ctr - Sacramento
  • San Francisco AIDS Clinic / San Francisco Gen Hosp - San Francisco
  • San Francisco Veterans Administration Med Ctr - San Francisco

Florida

  • Miami Veterans Administration Med Ctr - Miami
  • Univ of South Florida - Tampa

New York

  • Mem Sloan - Kettering Cancer Ctr - New York
  • SUNY / Health Sciences Ctr at Syracuse - Syracuse

Colorado

  • Denver Public Health Dept - Denver

Illinois

  • Northwestern Univ Med School - Chicago

Washington

  • Northwest Family Ctr at the Harbor View Med Ctr - Seattle

Trial Details

FieldValue
Phase Phase 3
Bristol-Myers Squibb

1,025 total trials

What the finished NCT00002067 record still lists

NCT00002067 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.

The record links to 3 conditions, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which Megestrol acetate is the first listed.

NCT00002067 lists 14 locations in 6 states (California, Florida, New York).

Frequently Asked Questions

What is clinical trial NCT00002067 about?

NCT00002067 is a clinical study titled "A Study Comparing Megestrol Acetate at 800 mg/Day, and Placebo in AIDS Patients With Anorexia and Cachexia". To compare the effects of megestrol acetate and placebo on body weight, anorexia, cachexia, calorie intake, and nutritional parameters of patients with a confirmed diagnosis of AIDS. To determine whether megestrol acetate relative to placebo improves the perception of well-being among AIDS patients ...

What is the current status of trial NCT00002067?

This trial is currently completed. It is a Phase 3 study.

What conditions does trial NCT00002067 study?

This clinical trial studies the following conditions: HIV Infections, Cachexia, Anorexia.

What interventions are being tested in trial NCT00002067?

The interventions under investigation include: Megestrol acetate (DRUG).

Who is sponsoring clinical trial NCT00002067?

This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00002067 being conducted?

This trial has 14 study locations across California, Colorado, Florida, Illinois, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Related registry views

Source: ClinicalTrials.gov NCT00002067, the US trial registry maintained by the National Library of Medicine. NCT00002067 (unsized enrollment · multi site footprint · completed) retrieved and formatted by PlainTrial, see methodology.